Theralink Technologies, Inc.
THER · OTC
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $0 |
| % Growth | 6.8% | 12.3% | 179% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 79.2% | 60.4% | 76.8% | 71% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $9 | $12 | $6 | $3 |
| SG&A Expenses | $9 | $12 | $6 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9 | $12 | $6 | $3 |
| Operating Income | -$9 | -$12 | -$6 | -$3 |
| % Margin | -1,479.8% | -2,049.6% | -1,100.9% | -1,852.2% |
| Other Income/Exp. Net | -$5 | -$1 | $0 | $0 |
| Pre-Tax Income | -$31 | -$13 | -$5 | -$3 |
| Tax Expense | $17 | $0 | $0 | $0 |
| Net Income | -$31 | -$13 | -$6 | -$3 |
| % Margin | -5,093.6% | -2,245% | -1,106.2% | -1,772.1% |
| EPS | -0.5 | -0.22 | -0.1 | -3.79 |
| % Growth | -127.3% | -120% | 97.4% | – |
| EPS Diluted | -0.005 | -0.002 | -0.001 | -0.001 |
| Weighted Avg Shares Out | 62 | 59 | 54 | 1 |
| Weighted Avg Shares Out Dil | 6,151 | 5,881 | 5,370 | 2,562 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $17 | $1 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$9 | -$11 | -$5 | -$3 |
| % Margin | -1,439.1% | -2,016% | -1,064.1% | -1,792.8% |